Literature DB >> 31025272

Predictors of cognitive behavioral therapy outcomes for insomnia in veterans with post-traumatic stress disorder.

Ali A El-Solh1,2,3, Nathan O'Brien4, Morohunfolu Akinnusi5, Sumit Patel6,7, Leela Vanguru6,7, Chathura Wijewardena6,7.   

Abstract

BACKGROUND: Insomnia is a well-recognized co-morbid condition in veterans with post-traumatic stress disorder (PTSD) with negative personal and social consequences. Cognitive behavioral therapy (CBT) is considered an efficacious treatment, yet little attention has been devoted to treatment response in this population. The aim of this study was to identify factors that may predict clinical response to CBT for insomnia (CBT-I) in veterans with PTSD.
METHODS: A retrospective chart review of 136 veterans with PTSD-related insomnia was conducted. Epworth Sleepiness Score (ESS), PTSD Checklist (PCL), and Insomnia Severity Index (ISI) were assessed at baseline. We converted prescribed antidepressant and hypnotic dosages before and after CBT-I to dose equivalent of fluoxetine diazepam, respectively. A 6-point reduction or greater in ISI scores at 6-month follow-up visit was defined as CBT-I responsiveness.
RESULTS: CBT-I responsiveness was observed in 47% of veterans with PTSD. Seventy-seven percent completed treatment. Lack of perceived benefit was the most given reason for failure to return for follow-up. In contrast to hypnotics, antidepressants usage decreased in those who had experienced benefit from CBT-I (p = 0.001). Younger age, non-white race, and use of hypnotics prior to behavioral therapy were independently associated with lack of response to CBT-I.
CONCLUSIONS: While CBT-I ameliorates insomnia in veterans with PTSD, the use of hypnotics prior to instituting behavioral therapy may negatively affect the response rate to CBT-I. Future studies should examine whether racial and cultural influences on the generation of insomnia in veterans with PTSD affects the response to CBT-I.

Entities:  

Keywords:  Cognitive behavioral therapy; Hypnotics; Insomnia; Post-traumatic stress disorder; Race

Mesh:

Substances:

Year:  2019        PMID: 31025272     DOI: 10.1007/s11325-019-01840-4

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  41 in total

1.  Validation of the Insomnia Severity Index as an outcome measure for insomnia research.

Authors:  C H. Bastien; A Vallières; C M. Morin
Journal:  Sleep Med       Date:  2001-07       Impact factor: 3.492

Review 2.  Resilience: research evidence and conceptual considerations for posttraumatic stress disorder.

Authors:  Elizabeth A Hoge; Eloise D Austin; Mark H Pollack
Journal:  Depress Anxiety       Date:  2007       Impact factor: 6.505

Review 3.  Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management.

Authors:  Michael J Maher; Simon A Rego; Gregory M Asnis
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Adapted cognitive behavioral group therapy for depressed low-income African American women.

Authors:  Laura P Kohn; Tatia Oden; Ricardo F Muñoz; Ayinka Robinson; Daria Leavitt
Journal:  Community Ment Health J       Date:  2002-12

5.  Predicting clinically significant response to cognitive behavior therapy for chronic insomnia in general medical practice: analysis of outcome data at 12 months posttreatment.

Authors:  C A Espie; S J Inglis; L Harvey
Journal:  J Consult Clin Psychol       Date:  2001-02

6.  Prolonged exposure in patients with chronic PTSD: predictors of treatment outcome and dropout.

Authors:  A van Minnen; A Arntz; G P J Keijsers
Journal:  Behav Res Ther       Date:  2002-04

7.  Treatment of residual insomnia after CBT for PTSD: case studies.

Authors:  Jason C DeViva; Claudia Zayfert; Wilfred R Pigeon; Thomas A Mellman
Journal:  J Trauma Stress       Date:  2005-04

8.  The effects of chronic valproate and diazepam in a mouse model of posttraumatic stress disorder.

Authors:  Song Li; Yukihisa Murakami; Minwei Wang; Kozo Maeda; Kinzo Matsumoto
Journal:  Pharmacol Biochem Behav       Date:  2006-10-10       Impact factor: 3.533

9.  Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder.

Authors:  Marshall E Cates; Melanie H Bishop; Lori L Davis; Joette S Lowe; Thomas W Woolley
Journal:  Ann Pharmacother       Date:  2004-07-13       Impact factor: 3.154

10.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

View more
  5 in total

Review 1.  Sleep in PTSD: treatment approaches and outcomes.

Authors:  Katherine E Miller; Janeese A Brownlow; Philip R Gehrman
Journal:  Curr Opin Psychol       Date:  2019-08-23

Review 2.  Sleep Apnea and Insomnia: Emerging Evidence for Effective Clinical Management.

Authors:  Jason C Ong; Megan R Crawford; Douglas M Wallace
Journal:  Chest       Date:  2020-12-10       Impact factor: 9.410

Review 3.  We know CBT-I works, now what?

Authors:  Alexandria Muench; Ivan Vargas; Michael A Grandner; Jason G Ellis; Donn Posner; Célyne H Bastien; Sean Pa Drummond; Michael L Perlis
Journal:  Fac Rev       Date:  2022-02-01

Review 4.  Selecting a pharmacotherapy regimen for patients with chronic insomnia.

Authors:  Amanda B Hassinger; Nikolas Bletnisky; Rizwan Dudekula; Ali A El-Solh
Journal:  Expert Opin Pharmacother       Date:  2020-03-23       Impact factor: 3.889

5.  Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder.

Authors:  Linnae Ponte; Lisa Jerome; Scott Hamilton; Michael C Mithoefer; Berra B Yazar-Klosinski; Eric Vermetten; Allison A Feduccia
Journal:  J Trauma Stress       Date:  2021-06-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.